Bluejay Diagnostics, Inc. (BJDX) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Bluejay Diagnostics, Inc. (BJDX) closed at USD 0.79 on 2026-10-14, a change of -91.1 % over the past year, with a market capitalization of USD 3.48M.

Bluejay Diagnostics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Bluejay Diagnostics, Inc. key figures

Previous close

USD 0.79 (2026-10-14)

1-year change

-91.1 %

Market cap

USD 3.48M

Enterprise value

USD -6.04M

P/E ratio (trailing)

-0.23

P/E ratio (forward)

-2.44

EPS (trailing)

-3.39

EPS (forward)

-0.32

PEG ratio

n/a

Price to book

0.16

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.05

Employees

6

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Bluejay Diagnostics, Inc. and compare it with other stocks.